|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology显示文摘 | Bernard Levin David A. Lieberman Beth McFarland Kimberly S. Andrews Durado Brooks John Bond Chiranjeev Dash Francis M. Giardiello Seth Glick David Johnson C. Daniel Johnson Theodore R. Levin Perry J. Pickhardt Douglas K. Rex Robert A. Smith Alan Thorson S | 2008 | Gastroenterology2008，，5： | 8 |
| 2 | Multitarget stool DNA for colorectal cancer screening:A review and commentary on the United States Preventive Services Draft Guidelines显示文摘Multitarget stool DNA(mt-sDNA) testing was approved for average risk colorectal cancer(CRC) screening by the United States Food and Drug Administration and thereafter reimbursed for use by the Medicare program(2014).The United States Preventive Services Task Force(USPSTF) October 2015 draft recommendation for CRC screening included mt-s DNA as an 'alternative' screening test that 'may be useful in select clinical circumstances',despite its very high sensitivity for early stage CRC.The evidence supporting mt-s DNA for routine screening use is robust.The clinical efficacy of mt-s DNA as measured by sensitivity,specificity,life-years gained(LYG),and CRC deaths averted is similar to or exceeds that of the other more specifically recommended screening options included in the draft document,especially those requiring annual testing adherence.In a population with primarily irregular screening participation,tests with the highest point sensitivity and reasonable specificity are more likely to favorably impact CRC related morbidity and mortality than those depending on annual adherence.This paper reviews the evidence supporting mt-s DNA for routine screening and demonstrates,using USPSTF's modeling data,that mt-s DNA at three-year intervals provides significant clinical net benefits and fewer complications per LYG than annual fecal immunochemical testing,high sensitivity guaiac based fecal occult blood testing and 10-year colonoscopy screening. | Barry M Berger Bernard Levin Robert J Hilsden | 2016 | World Journal of Gastrointestinal Oncology2016，8，5： | 3 |
| 3 | Colorectal cancer prevention显示文摘 | Bernard Levin | 2005 | J Clin Oncology2005，23，2： | 1 |
| 4 | Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial显示文摘 | Joel E. Richter Peter J. Kahrilas John Johanson Paul Maton Jeffrey R. Breiter Clara Hwang Victoria Marino Bernard Hamelin Jeffrey G. Levine | 2001 | The American Journal of Gastroenterology2001，，3： | 1 |
| 5 | Studies on The Mechanism of The Formation of The Penicillin Antligen III 显示文摘 | Levine Bernard B Ovary Zoltan | 1961 | J Exp Med1961，114，2： | 1 |
| 6 | Meta-analyses of colorectal cancer risk factors显示文摘 | Constance M. Johnson Caimiao Wei Joe E. Ensor Derek J. Smolenski Christopher I. Amos Bernard Levin Donald A. Berry | 2013 | Cancer Causes & Control2013，，6： | 1 |
| 7 | Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society显示文摘 | Sidney J. Winawer Ann G. Zauber Robert H. Fletcher Jonathon S. Stillman Michael J. O’Brien Bernard Levin Robert A. Smith David A. Lieberman Randall W. Burt Theodore R. Levin John H. Bond Durado Brooks Tim Byers Neil Hyman Lynne Kirk Alan Thorson Clifford | 2006 | Gastroenterology2006，，6： | 1 |
| 8 | Guidelines for Colonoscopy Surveillance After Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society显示文摘 | Sidney J. Winawer Ann G. Zauber Robert H. Fletcher Jonathon S. Stillman Michael J. O'Brien Bernard Levin Robert A. Smith David A. Lieberman Randall W. Burt Theodore R. Levin John H. Bond Durado Brooks Tim Byers Neil Hyman Lynne Kirk Alan Thorson Clifford | 2006 | Gastroenterology2006，，6： | 1 |
| 9 | Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer显示文摘 | Ranjan Sur Bernard Donde Conrad Falkson Sheikh Nisar Ahmed Victor Levin Subir Nag Raimond Wong Glenn Jones | 2004 | Brachytherapy2004，，4： | 1 |
| 10 | A controlled trial of azathioprine in Crohn’s disease显示文摘 | James L. Rosenberg MD Bernard Levin MD Alfred J. Wall MD Joseph B. Kirsner MD PhD FACP | 1975 | The American Journal of Digestive Diseases1975，，8： | 1 |
| 11 | 功率半导体封装外包业务将迅速增长显示文摘功率半导体封装领域在业界一直没有很大的吸引力,也从未能产生大量利润.然而,所有这些可能都会很快改变,特别是在需要高成本新封装方式的高端功率半导体产品领域. | Bernard Levine | 2003 | 世界电子元器件2003，，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员